These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16822302)

  • 21. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study.
    Siegler A; Huxley-Reicher Z; Maldjian L; Jordan R; Oliver C; Jakubowski A; Kunins HV
    Drug Alcohol Depend; 2017 Oct; 179():124-130. PubMed ID: 28772172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
    Coffin PO; Fuller C; Vadnai L; Blaney S; Galea S; Vlahov D
    J Urban Health; 2003 Jun; 80(2):288-90. PubMed ID: 12791804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Young people who use drugs engaged in harm reduction programs in New York City: Overdose and other risks.
    Calvo M; MacFarlane J; Zaccaro H; Curtis M; Cabán M; Favaro J; Passannante MR; Frost T
    Drug Alcohol Depend; 2017 Sep; 178():106-114. PubMed ID: 28645060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
    Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
    Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses?
    Gaston RL; Best D; Manning V; Day E
    Harm Reduct J; 2009 Sep; 6():26. PubMed ID: 19781073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods.
    Ashrafioun L; Gamble S; Herrmann M; Baciewicz G
    Subst Abus; 2016; 37(1):76-81. PubMed ID: 26514071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.
    Chronister KJ; Lintzeris N; Jackson A; Ivan M; Dietze PM; Lenton S; Kearley J; van Beek I
    Drug Alcohol Rev; 2018 May; 37(4):464-471. PubMed ID: 27071354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The implementation of a naloxone rescue program in university students.
    Panther SG; Bray BS; White JR
    J Am Pharm Assoc (2003); 2017; 57(2S):S107-S112.e2. PubMed ID: 28063773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A qualitative study of overdose responses among Chicago IDUs.
    Sherman SG; Gann DS; Scott G; Carlberg S; Bigg D; Heimer R
    Harm Reduct J; 2008 Jan; 5():2. PubMed ID: 18218071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing deaths from rising opioid overdose in the US - the promise of naloxone antidote in community-based naloxone take-home programs.
    Straus MM; Ghitza UE; Tai B
    Subst Abuse Rehabil; 2013 Sep; 2013(4):65-72. PubMed ID: 24273417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unintentional opioid overdose deaths in New York City, 2005-2010: a place-based approach to reduce risk.
    Siegler A; Tuazon E; Bradley O'Brien D; Paone D
    Int J Drug Policy; 2014 May; 25(3):569-74. PubMed ID: 24412006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of naloxone distribution to likely bystanders: Results of an agent-based model.
    Keane C; Egan JE; Hawk M
    Int J Drug Policy; 2018 May; 55():61-69. PubMed ID: 29524734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do heroin overdose patients require observation after receiving naloxone?
    Willman MW; Liss DB; Schwarz ES; Mullins ME
    Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
    Katzman JG; Takeda MY; Bhatt SR; Moya Balasch M; Greenberg N; Yonas H
    J Addict Med; 2018; 12(2):113-118. PubMed ID: 29227321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice trainees.
    Klimas J; Egan M; Tobin H; Coleman N; Bury G
    BMC Med Educ; 2015 Nov; 15():206. PubMed ID: 26590066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study.
    Marshall C; Perreault M; Archambault L; Milton D
    Int J Drug Policy; 2017 Mar; 41():19-28. PubMed ID: 28027483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.